STIM — Neuronetics Inc
NASDAQ · Healthcare · Medical Devices
$2.84
+$0.00 (+0.00%)
Neuronetics Inc (STIM) is a medical devices company listed on NASDAQ. It is led by Daniel L. Reuvers, based in 3222 Phoenixville Pike, Malvern, PA, United States, 19355, with about 658 employees. Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Latest reported STIM revenue for 2025-09-30 was $37.3M. Net income was -$9.4M. Revenue was down 2.1% from 2025-06-30 to 2025-09-30. STIM currently screens at market cap $84.2M.
Use this STIM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the STIM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the STIM SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuronetics Inc even when a live quote feed is slow.
About Neuronetics Inc
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
STIM Key Statistics
Market Cap
$84.20M
Volume
196,490
Previous Close
$2.98
Day Range
$2.88 – $2.99
P/B Ratio
6.35
EPS
-$1.38
Revenue
$74.89M
Net Income
-$43.73M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+5.0%
Profit Margin
-58.4%
Employees
658
STIM Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $74.89M | $71.35M | $65.21M | $55.31M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$43.73M | -$30.19M | -$37.16M | -$31.19M |
| EPS (Diluted) | -$1.38 | -$1.05 | -$1.38 | -$1.22 |
Total Assets
$140.90M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$18.46M
Operating Cash Flow
-$31.00M
Free Cash Flow
$0.00
Neuronetics Inc Company Information
- CEO, President & Director
- Daniel L. Reuvers
- Headquarters
- 3222 Phoenixville Pike, Malvern, PA, United States, 19355
- Website
- neurostar.com/neuronetics
- Phone
- 877 600 7555
- IPO / Founded
- 2018-06-28
- Sector
- Healthcare
- Industry
- Medical Devices